SST and depressive disorder: In this work, we showed in silico that α5-PAM therapeutic doses, which effectively recover cortical microcircuit EEG, spiking activity and function, can be predicted from simulated EEG biomarkers of depression severity in terms of reduced SST interneuron inhibition.